Recently, a therapeutic trial of three doses of recombinant IL-7 applied to increase peripheral T cell numbers in patients with T cell lymphopenia led to induction of systemic lupus erythematosus (SLE) in one out of nine patients [40]. Here, IL7 is linked to systemic lupus erythematosus.